Hims & Hers Health Inc (NYSE:HIMS) shares have surged 32% to $50.48 since Tuesday's session open, following the company’s first-quarter earnings report released late Monday.

Subscriber growth was a key driver, climbing 38% year-over-year to 2.4 million. Gross margin stood at 73%, with operating cash flow of $109.1 million and free cash flow of $50.1 million.

CEO Andrew Dudum highlighted strong momentum entering 2025, citing growing demand for accessible and personalized healthcare. The company reaffirmed full-year revenue guidance of $2.3 billion to $2.4 billion and projected at least $6.5 billion in annual revenue by 2030, alongside $1.3 billion in adjusted EBITDA.

Despite a slightly conservative second-quarter revenue outlook of $530–$550 million, compared to the expected $564.56 million estimates, investor enthusiasm remains high as the company shows progress scaling its platform.

Read Also: That Cake Is Already Baked,’ Says Bill Ackman, Warning U.S.-China Tariff War Is Driving Companies Out Of China For Good

How To Buy HIMS Stock

By now you're likely curious about how to participate in the market for Hims & Hers Health – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

According to data from Benzinga Pro, HIMS has a 52-week high of $72.98 and a 52-week low of $11.64.